Athens, Greece, 12-14 October 2022


Clicking each of the link will open the file in PDF format (Adobe Reader needed).
The use of the content, even partial, is not allowed without the prior agreement of the author. Please contact EQALM (This email address is being protected from spambots. You need JavaScript enabled to view it.) for more information.


Topic Presentation Speaker
EQA for rare diseases Ursula Unterberger
Update on the roll out of the in vitro diagnostic medical devices regulation 2017/746 (IVDR)   Christa Cobbaert
Update on ISO 17043 / IEC 17043   Olivier Pierson
An example of providing EQA reports that become part of the participants quality management system Tony Badrick
Extended use of EQA-results     Mathias Karlsson
Experiences in EQA for phlebotomy and urine sampling     Jonna Pelanti
Development of an External Quality Assessment (EQA) Programme for Point of Care (POCT) Respiratory Viruses   Gareth Davies
Biological Variation in haemostasis variables   Martine van Essen-Hollestelle
Intra-type variability as a measure of the resilience to operator and environmental influences of POCT diagnostic devices   Christoph Buchta
Patient Based EQA   Rachel Marrington
Assessment and risk estimation of biotin interference in immunoassays   Alexander Haliassos & Serafeim Karathanos
Expanding the availability and coverage of EQA programmes in Africa   Beatrice van der Puije
Results from a comprehensive, international external quality assessment for SARS-CoV-2-specific antibody assays - the EQALM-SARSCoV-2 antibody study with 1704 participant laboratories from 65 countries   Lukas Weseslindtner
Interest in low antibody control samples in viral serology - Methods of production/validation of samples   Marcel Miedougé
WG Virtual microscopy: EQALM VM Sharing Platform and Guidelines -- István Juhos
WG Haemostasis: HIL survey in coagulation    Ann Helen Kristoffersen
Adam Uldall Lecture     
EQA, is there a benefit for the patient?! -- Piet Meijer
Category 5 or 6 EQA programs   Tony Badrick
Why EQA providers should use commutable control material and how to perform commutability studies   Sverre Sandberg
What to do when reference measurement procedures show different results?   Anja Kessler
EQALM Central Database   Wim Coucke
Harmonising Reference Intervals in Haematology   Barbara De la Salle
Correlation between EQA data as a key to determine optimum EQA frequency   Wim Coucke
Analytical performance specifications - What does a limit of total error mean and when can it be used   Wim Coucke (Mohamed Rida Soumali)
EQA for POCT glucose - consequences for patient diagnostics   Anne Stavelin